Kayihura Manigaba, Pharm.D., BCIDP

Clinical Assistant Professor

Department: Pharmacotherapy & Translational Research

Business Phone: (352) 273-8474

Business Email: manigk@ufl.edu

CV: View Curriculum Vitae

About Kayihura Manigaba

Dr. Kayihura Manigaba received his doctor of pharmacy degree from the University of Tennessee College of Pharmacy in Memphis, TN. He then completed an ASHP-accredited PGY-1 Pharmacy Residency, followed by an ASHP-accredited PGY2 Residency in Infectious Diseases at UF Health Shands Hospital in Gainesville, Florida. In December 2021, Dr. Manigaba joined the University of Florida College of Pharmacy from North Florida Regional Medical Center (NFRMC), where he was an Advanced Clinical Pharmacist in Infectious Diseases and, most recently, a Clinical Pharmacy Manager. While at NFRMC, Dr. Manigaba contributed to the UF College of Pharmacy program by teaching in the Patient Care 2 course and precepting APPE students. Dr. Manigaba is board certified in infectious diseases pharmacy, and his professional and research areas of interest include infectious diseases, therapeutic drug monitoring, treatment of multidrug-resistant pathogens, and antimicrobial stewardship. He is a member of the American Society of Health-System Pharmacists and the American College of Clinical Pharmacy.

Teaching Profile

Courses Taught

2021-2023

PHA5782C Patient Care 2: Introduction to Infectious Disease and Oncology

2022-2023

PHA5784C Pt Care 4: GI and Renal

2022-2023

PHA5166L Prof Skills Lab Vi

2022-2023

PHA5787C Pt Care 5: Endo

2022

PHA5163L Prac Skills Lab III

Publications

2022

A waterfall of susceptibility results: impact of microbiology testing cascade for MDROs.

Diagnostic microbiology and infectious disease. 104(1) [DOI] 10.1016/j.diagmicrobio.2022.115731. [PMID] 35841735.

1 citation · PubMed · Publisher’s Site

2021

A new frontier: navigating hospital pharmacy practice during the COVID-19 pandemic.

Journal of Research in Pharmacy. 25(6)

2020

COVID-19: The Culprit, the People and Lessons Learned

HCA Healthcare Journal of Medicine . 1(4)

2020

Remdesvir-warfarin interaction: A case report

HCA Healthcare Journal of Medicine. 1(COVID-19)

2018

SCAN: A novel approach for vancomycin time-out.

Infection control and hospital epidemiology. 39(12):1501-1503 [DOI] 10.1017/ice.2018.249. [PMID] 30303049.

3 citations · PubMed · Publisher’s Site

2018

Training a Drug to Do New Tricks: Insights on Stability of Meropenem Administered as a Continuous Infusion.

Microbiology insights. 11 [DOI] 10.1177/1178636118804549. [PMID] 30349291.

4 citations · PubMed · Publisher’s Site

2017

Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.

Antimicrobial agents and chemotherapy. 61(9) [DOI] 10.1128/AAC.00651-17. [PMID] 28630186.

29 citations · PubMed · Publisher’s Site

2015

Multidrug Transporters and Alterations in Sterol Biosynthesis Contribute to Azole Antifungal Resistance in Candida parapsilosis.

Antimicrobial agents and chemotherapy. 59(10):5942-50 [DOI] 10.1128/AAC.01358-15. [PMID] 26169412.

56 citations · PubMed · Publisher’s Site

2013

Ethnic differences in DNA methyltransferases expression in patients with systemic lupus erythematosus.

Journal of clinical immunology. 33(2):342-8 [DOI] 10.1007/s10875-012-9803-z. [PMID] 23054340.

24 citations · PubMed · Publisher’s Site

Contact Details

Phones:

Business:: (352) 273-8474

Emails:

Business:: manigk@ufl.edu

Addresses:

Business Mailing:: PO Box 100486
GAINESVILLE FL 32610